Psoriasis boosts diabetes risk, study finds
NEW YORK — Research published in the latest issue of Archives of Dermatology, a JAMA network publication, found that an inflammatory skin disease is an independent risk for Type 2 diabetes.
Researchers with the Perelman School of Medicine at the University of Pennsylvania compared 108,132 people with psoriasis to 430,716 matched patients without psoriasis, and determined patients with mild psoriasis had an 11% increased risk of diabetes, while patients with severe psoriasis had a 46% higher risk, compared with patients without psoriasis. The study also looked at treatments used by those diagnosed with diabetes, and found that the patients with both psoriasis and diabetes were more likely to require pharmacological treatment of diabetes, compared with diabetics without psoriasis.
Both psoriasis and diabetes are diseases caused by chronic inflammation, the study authors noted, and share a common pathway — known as TH-1 cytokines — which can promote insulin resistance and metabolic syndrome, as well as promote inflammatory cytokines known to drive psoriasis.
"These data suggest that patients with psoriasis are at increased risk for developing diabetes even if they don’t have common risk factors such as obesity," said senior author Joel Gelfand, associate professor of dermatology in the Perelman School of Medicine. "Patients with psoriasis should eat a healthy diet, get regular exercise, and see their physician for routine preventative health screenings such as checks of blood pressure, cholesterol and blood sugar."
Mscripts releases multilingual functionality for its prescription management app
SAN FRANCISCO — Pharmacy customers who use the Mscripts application to order, refill and manage their prescriptions now can do so in English or Spanish, the company announced Wednesday. They also can receive reminders to take their medications, making it easier to remain adherent to prescribed medication regimes.
Mscripts supports the mobile offerings of large pharmacy chains across the country.
"Many of our customers speak Spanish at home," stated Sergio Campos, chief information officer at Navarro Discount Pharmacies. "They are more comfortable using the Navarro Pharmacy Mobile App in their native language. We are thrilled to be able to provide this service to our customers."
The app changes languages based on the user’s phone language settings.
"It takes more time to read something in a second language, and that delay is frustrating when you are using a technology as nimble as mobile," noted Mark Cullen, CEO of Mscripts. "Our customers should delight in the speed and convenience of managing their prescriptions, regardless of what language they speak. Mscripts is committed to providing ease of use in healthcare management. A significant factor in taking medications as prescribed is refilling medication on time and taking it on schedule. The bilingual service allows people to easily stay on top of their prescriptions."
Hamacher Resource Group to deliver presentation on optimal diabetes marketing
WAUKESHA, Wis. — Hamacher Resource Group on Tuesday announced it will present “Marketing Diabetes in the Retail Setting” June 21 at the Marketing Diabetes Prevention and Awareness Conference in Atlanta.
Dave Wendland, VP and part of the owners group at HRG, will share ideas about how retail pharmacies can collaborate with suppliers to bring innovation to the diabetes care category to better serve patients, capture incremental sales and significantly grow the category’s reach.
“There are 25.8 million Americans with diabetes, and sadly, that number continues to grow,” Wendland said. “Because these patients are largely self-managing their condition, they can benefit from shopping for supplies and complimentary products at a pharmacy where they can also receive consultation from an expert. A holistic approach to care at retail is critical to make the shopping experience for these patients more intuitive and convenient. Simplifying the shopping experience can result in a bigger market basket.”